Using a new technology and computational method, researchers from Fred Hutch Cancer Center and The University of Texas MD ...

Researchers randomized patients with advanced neuroendocrine tumors 2:1 to receive either cabozantinib or placebo.

The OHSU researchers call their test “PAC-MANN,” which stands for “protease activity-based assay using a magnetic nanosensor.

A new blood test could help doctors detect pancreatic cancer earlier, potentially improving survival rates for one of the ...

The problem with pancreatic cancer is that we often catch it too late,” he stated. The PAC-MANN test aims to enable ...

Cedars-Sinai investigators are developing a tool using artificial intelligence to help predict pancreatic cancer in Black ...

Phase I clinical trials are the first step in testing a new treatment or combination of treatments. These trials often ...